Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000489561 | SCV000577470 | uncertain significance | not specified | 2017-03-28 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the FAT4 gene. The T2032A variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The T2032A variant is observed in 20/66732 (0.03%) alleles from individuals of European background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The T2032A variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this substitution occurs at a position where amino acids with similar properties to Threonine are tolerated across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Labcorp Genetics |
RCV001700194 | SCV002370621 | likely benign | not provided | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001700194 | SCV003833972 | uncertain significance | not provided | 2021-02-05 | criteria provided, single submitter | clinical testing | |
Clinical Genomics Laboratory, |
RCV003458201 | SCV004177063 | uncertain significance | Hennekam lymphangiectasia-lymphedema syndrome 2 | 2023-09-29 | criteria provided, single submitter | clinical testing | The FAT4 c.6094A>G (p.Thr2032Ala) variant was identified at a near heterozygous allelic fraction. This variant, to our knowledge, has not been reported in the literature. This variant has been reported in the ClinVar database as a variant of uncertain significance by multiple submitters and likely benign variant by one submitter (ClinVar ID: 426899). Computational predictors are uncertain as to the impact of this variant on FAT4 function. Due to limited information, and based on ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), the clinical significance of this variant is uncertain at this time. |
Clinical Genetics, |
RCV001700194 | SCV001919072 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001700194 | SCV001964739 | uncertain significance | not provided | no assertion criteria provided | clinical testing |